Provident Wealth Management’s Amgen AMGN Stock Holding History

Provident Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50	Closed	-$13K	–	71
2020 Q3	$13K	Buy	+50	New	+$12.4K	0.02%	136

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Provident Wealth Management's AMGN Position: Q4 2020 in Review

Provident Wealth Management sold out of Amgen (AMGN) in Q4 2020, closing a stake of 50 shares — an estimated $13K sold.

Provident Wealth Management first reported a position in AMGN in Q3 2020 and held it in 1 quarter. The position peaked at $13K in Q3 2020. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Provident Wealth Management reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Provident Wealth Management sold 50 Amgen shares in Q4 2020, an estimated $13K.
Provident Wealth Management first reported a position in Amgen in Q3 2020 and held it in 1 quarter.
Provident Wealth Management's Amgen position peaked at $13K in Q3 2020.
2,219 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Provident Wealth Management's 13F filing for Q4 2020, filed 20 Jan 2021.